权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Study the link of autophagy dysfunction to allergic and neutrophilic asthma onset

研究自噬功能障碍与过敏性和中性粒细胞性哮喘发病的联系

基本信息

批准号：
10204106
负责人：
OMID AKBARI
金额：
$ 73.09万
依托单位：
UNIVERSITY OF SOUTHERN CALIFORNIA
依托单位国家：
美国
项目类别：
财政年份：
2020
资助国家：
美国
起止时间：
2020-07-01 至 2025-06-30
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10204106
关键词：
Ablation Affect Aging Allergens Allergic Allergic Disease Allergic inflammation Animal Model Animals Antigen-Presenting Cells Antigens Asthma Autophagocytosis Biopsy Bronchoalveolar Lavage Fluid CD11c Antigens Cell physiology Cell surface Cells Childhood Asthma Chronic Chronic lung disease Clinical Clinical Data Clinical Trials Collaborations Complement Data Dendritic Cells Development Disease Effector Cell Ensure Extrinsic asthma FOXP3 gene Functional disorder Generations Genes Genetic Goals Human Hypersensitivity ITGAX gene Immune Immune response Impairment In Vitro Inflammation Interleukin-1 Interleukin-10 Laboratories Lead Left Leukocytes Light Link Liquid substance Lung Lung Inflammation Lung diseases Lysosomes Malignant Neoplasms Measures Modeling Mus Nerve Degeneration Organelles Organism Pathogenesis Pathology Pathway interactions Patients Peptides Peripheral Blood Mononuclear Cell Phenotype Physiological Play Population Pre-Clinical Model Process Production Proteins Protocols documentation Publications Publishing Pulmonology Pyroglyphidae Regulatory Pathway Regulatory T-Lymphocyte Resolution Role Sampling Science Scientist Severities Steroid Resistance System T-Lymphocyte Technology Testing Therapeutic Effect Therapeutic Uses Time Tissues Transgenic Organisms Translating adaptive immune response airway hyperresponsiveness asthmatic patient base clinically translatable cohort conditional knockout cytokine design effective therapy experience experimental study genetic manipulation genetic variant genome wide association study improved insight model design mouse model neutrophil new technology novel novel strategies pathogen peripheral blood pre-clinical pulmonary function repository single-cell RNA sequencing transcription factor translational approach

项目摘要

Abstract The long-term goal of this study is to increase our understanding of the immune mechanisms involved in the pathogenesis of allergic diseases and asthma. Autophagy is an evolutionarily conserved and highly regulated essential homeostatic process that ensures lysosome-dependent bulk degradation of cytosolic proteins and organelles. Alterations in autophagy have been implicated in numerous conditions afflicting humans, including aging, cancer, neurodegenerative processes, and immune responses, as autophagy is essential for the generation of both innate and adaptive immune responses to pathogens. This project is motivated by recent published data from our laboratory and others, demonstrating that abrogation of autophagy, particularly in dendritic cells (DCs), induces severe airway hyperreactivity (AHR) in animal models (J Allergy Clin Immunol, 2016; Science. 2017). Moreover, several studies clearly demonstrate that genetic variants in Atg5, a critical gene in autophagy, are significantly associated with childhood asthma. In support of those studies, our preliminary results suggest that: A) treatment with autophagy inducers reduces AHR in animal models sensitized with allergens, B) enhancement of autophagy in dendritic cells induces IL-10 and significantly up- regulates PD-L2, which in turn robustly polarizes naïve T cells towards Foxp3+ regulatory T cells, C) genetic ablation of autophagy, particularly in DCs, induces steroid-resistant AHR in murine models, and D) autophagy is severely impaired in pulmonary dendritic cells obtained from patients with moderate to severe asthma. We now propose to investigate if enhancement of autophagy, particularly among antigen presenting cells, ameliorates pathology associated with asthma, suppresses unwanted lung inflammation and ultimately improves lung inflammation and function. To test this hypothesis, we first designed several approaches utilizing tissue-specific and conditional knockout murine models established in our laboratory. Second, we intend to modulate autophagy using a novel and robust autophagy inducer that was discovered recently by our collaborators at USC. Finally, we will extend our preliminary results in humans by assessing autophagy levels in the bronchoalveolar fluid and peripheral blood of patients with asthma, and determine if treatment with autophagy inducers can enhance immune-regulatory pathways. For the human studies we successfully established collaborations with UCSF pulmonary group and will utilized their lung biopsy repository samples obtained from well-defined cohorts of patients with asthma including neutrophilic asthma. Furthermore, we have assembled a team of scientists including a leading expert in autophagy and the chief of clinical pulmonology at USC to complement our laboratory's extensive experience in pre-clinical models of AHR. We believe that the results obtained from this study will provide novel insights into an important and previously unrecognized role of autophagy in asthma.

摘要